Bristol myers squibb co (BMY)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07
Revenues

26,145

22,561

20,776

19,427

16,560

15,879

16,385

17,621

21,244

19,484

18,808

17,715

15,617

Cost of Goods and Services Sold

8,078

6,467

6,014

4,969

3,909

3,932

4,619

4,610

5,598

5,277

5,140

5,316

4,919

Selling, General and Administrative Expense

4,871

4,551

4,751

4,979

4,841

4,822

4,939

4,220

4,203

3,686

3,946

4,140

3,941

Advertising and product promotion

-

-

-

-

-

-

-

797

957

977

1,136

1,181

1,097

Research and Development Expense

6,148

6,332

6,468

5,012

5,920

4,534

3,731

3,904

3,839

3,566

3,647

3,512

3,160

Amortization of Acquired Intangible Assets

1,135

97

97

-

-

-

-

-

-

-

-

-

-

Impairment charge for BMS-986094 intangible asset

-

-

-

-

-

-

-

1,830

-

-

-

-

-

Acquired in-process research and development

-

-

-

-

-

-

-

-

-

-

-

32

230

Provision for restructuring

-

-

-

-

-

-

-

-

-

-

136

215

180

Litigation expense, net

-

-

-

-

-

-

-

-

-

-

132

33

14

Equity in net income of affiliates

-

-

-

-

-

-

-

-

-

-

550

617

524

Gain on sale of ImClone shares

-

-

-

-

-

-

-

-

-

-

-

895

0

Other Nonoperating (Income) Expense

-938

854

1,685

1,448

187

-210

-205

80

334

93

381

-22

-77

Costs and Expenses

21,170

16,593

15,645

13,512

14,483

13,498

13,494

15,281

14,263

13,413

13,206

12,939

13,094

Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest

4,975

5,968

5,131

5,915

2,077

2,381

2,891

2,340

6,981

6,071

5,602

4,776

2,523

Income Tax Expense (Benefit)

1,515

1,021

4,156

1,408

446

352

311

-161

1,721

1,558

1,182

1,090

471

Net Earnings from Continuing Operations

-

-

-

-

-

-

-

-

-

-

4,420

3,686

2,052

Earnings, net of taxes

-

-

-

-

-

-

-

-

-

-

285

578

876

Gain on disposal, net of taxes

-

-

-

-

-

-

-

-

-

-

7,157

1,979

0

Net Earnings from Discontinued Operations

-

-

-

-

-

-

-

-

-

-

7,442

2,557

876

Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

3,460

4,947

975

4,507

1,631

2,029

2,580

2,501

5,260

4,513

11,862

6,243

2,928

Net Income (Loss) Attributable to Noncontrolling Interest

21

27

-32

50

66

25

17

541

1,551

1,411

1,250

996

763

Net Income (Loss) Attributable to Parent

3,439

4,920

1,007

4,457

1,565

2,004

2,563

1,960

3,709

3,102

10,612

5,247

2,165

Earnings Per Share [Abstract]
Net earnings from continuing operations attributable to Bristol-Myers Squibb Company

-

-

-

-

-

-

-

-

-

-

3,239

2,697

1,296

Net earnings from discontinued operations attributable to Bristol-Myers Squibb Company

-

-

-

-

-

-

-

-

-

-

7,373

2,550

869

Net Earnings Attributable to Bristol-Myers Squibb Company

3,439

4,920

1,007

4,457

1,565

-

-

-

-

-

-

5,247

2,165

Basic Earnings per Common Share from Continuing Operations Attributable to Bristol-Myers Squibb Company

-

-

-

-

-

-

-

-

-

-

1.63

1.36

0.65

Diluted Earnings per Common Share from Continuing Operations Attributable to Bristol-Myers Squibb Company

-

-

-

-

-

-

-

-

-

-

1.63

1.35

0.65

Earnings Per Share, Basic

2.02

3.01

0.61

2.67

0.94

1.21

1.56

1.17

2.18

1.80

5.35

2.64

1.09

Earnings Per Share, Diluted

2.01

3.01

0.61

2.65

0.93

1.20

1.54

1.16

2.16

1.79

5.34

2.62

1.09

Cash dividends declared per common share

-

-

-

-

1.49

1.45

1.41

1.37

1.33

1.29

1.25

1.24

1.15

Net product sales [Member]
Revenues

25,174

21,581

19,258

17,702

14,045

11,660

12,304

13,654

17,622

-

-

-

-

Alliance and other revenues [Member]
Revenues

971

980

1,518

1,725

2,515

4,219

4,081

3,967

3,622

-

-

-

-